Results 301 to 310 of about 5,782,005 (384)
Causal insights into multiple myeloma: The impact of circulating inflammatory proteins and metabolites. [PDF]
Zhang P, Li H, Huang Y, Sha H.
europepmc +1 more source
Use of murine myeloma protein M467 for detecting Salmonella spp. in milk
A. M. Smith, C. Jones
semanticscholar +1 more source
Targets for CAR Therapy in Multiple Myeloma. [PDF]
Bezborodova OA+10 more
europepmc +1 more source
In oncological patients SIR measures like the mGPS have great impact on prognosis at starting therapy. We recorded at admission for allo‐HCT the mGPS in 2201 patients: score 0 CRP/sALB normal; score 1 CRP >10mg/dl; score 2 CRP >10mg/dl + sALB <35g/L. Multivariate analysis revealed a significant impact with a low GPS score for OS: mGPS 1 vs.
Hartmut Bertz+11 more
wiley +1 more source
Heavy Chain Deposition Disease in Monoclonal Gammopathy of Renal Significance: A Prodrome of Multiple Myeloma Case and Literature Review. [PDF]
Gnanasampanthan S+3 more
europepmc +1 more source
The Role of Histone Methyltransferase SETDB1 in Normal and Malignant Hematopoiesis
In this review, we discuss the role of SETDB1 in gene regulation, including an overview of its structural features and key cofactors. We also highlight the lineage‐specific roles of SETDB1 in both normal hematopoietic processes and hematological malignancies, emphasizing its function as an immune checkpoint molecule that suppresses natural killer cell ...
Yu‐Hsuan Chang, Susumu Goyama
wiley +1 more source
Monoclonal gammopathy presenting with paraproteinemic keratopathy documented with anterior segment OCT: a case report. [PDF]
Nouira C+4 more
europepmc +1 more source
In the tumor microenvironment, selinexor suppresses tumor cell growth and prevents macrophages from polarizing to M2 populations. The lower concentration of selinexor decreases CAR‐T cell exhaustion, enhances its cytotoxicity, and upregulates NGFR expression to prompt CAR‐T cell proliferation.
Wenjing Luo+9 more
wiley +1 more source
Beyond the bone marrow: a review of therapeutic approaches for extramedullary disease in multiple myeloma and the significance of MRD assessment. [PDF]
Diaconescu D+4 more
europepmc +1 more source